Translational Video Series
Translational Science Dermatology Lecture Series from George Washington School of Medicine and Health Sciences
This ongoing evidence-based series from George Washington University, hosted by Adam Friedman, MD is comprised of expert guest lectures designed to provide dermatologists and residents with access to the latest bench-to-bedside research and practical pearls.
"Itch From Bedside to Bench" Click here
Dr. Gil Yosipovitch, Professor of Dermatology at University of Miami Miller School of Medicine, provides residents and physicians access to the latest bench research and practical pearls from a master in pruritus that will help them offer the highest quality evidence-based dermatological care.
Special thanks to Exeltis and Intraderm for support and/or exhibition at the live activity.
"Psoriasis: Biological Basis for Comorbidities" Click here
Dr. Abrar Qureshi, Professor and Chair of Department of Dermatology at The Warren Alpert Medical School of Brown University, reviews his research to uncover the biological basis for many of the co-morbidities associated with, and risk factors for, psoriasis. Through this clear and clinically oriented presentation, the common pathophysiological threads are elucidated with a focus on identifying preventive strategies and therapeutic targets for current and future treatments.
Special thanks to Celgene, Leo Pharma, Eli Lilly, and AbbVie for support and/or exhibition at the live activity.
"Update on pediatric inflammatory skin disorders: How pathogenesis informs treatment” Click here
Dr. Amy Paller, Walter J. Hamlin Professor and Chair of Dermatology & Professor of Pediatrics at Northwestern University Feinberg School of Medicine in Chicago, Illinois, delivers a presentation discussing the cause and treatment of pediatric Atopic Dematitis, including co-morbidities, epidermal barrier impairment, and compliance issues.
Special thanks to Encore Dermatology for support and/or exhibition at the live activity.
"Translational Research in Acne: Identifying Therapeutic Targets” Click here
Dr. Diane Thiboutot, endowed Professor of Dermatology and Associate Dean of Clinical and Translational Research Education at the Pennsylvania State University College of Medicine in Hershey, PA, underscores the extraordinary biological complexity of one of the most common skin diseases, Acne Vulgaris.
Special thanks to Valeant, Bayer, and Allergan for support and/or exhibition at the live activity.
"Targeting cAMP Signaling for the Treatment of Inflammatory Diseases of the Skin" Click here
Dr. Jon Zippin, Assistant Attending Dermatologist and Assistant Professor of Dermatology at Weill Medical College of Cornell, elucidates the complexity of cAMP biology and the translational impact of PDE4 inhibition as it relates to chronic inflammatory skin diseases. Tune in to learn why targeting this pathway is clinically meaningful but also where more work is needed to improve outcomes.
Special thanks to Celgene and Pfizer for support of and exhibition at this event.
"Advances in Melanoma Risk Assessment and Metastatic Disease Monitoring" Click here
Dr. David Polsky, Professor of Dermatology and Pathology, Alfred W. Kopf, MD Professor of Dermatologic Oncology in the Department of Dermatology at NYU Langone Medical Center delivers a stelar presentation on both developing tools to better stratify risk factors for melanoma, and identifying novel biomarkers to allow for melanoma treatment efficacy monitoring and progress.
Special thanks to Genentech for support of and exhibition at this event.
"Inante Immune Mechanisims - Translation to Novel Therapeutics For Skin Disease" Click here
Dr. Lloyd Miller, Associate Professor of Dermatology and Orthopedic Surgery at the Johns Hopkins School of Medicine, takes us on a translational tour of the innate immune response, highlighting specific aberrations in cutaneous pathology and drugable targets.
Special thanks to Novatis, Lilly, Allergan, Celgene, and Sanofi Regeneron, for support of and exhibition at this event.
"I see Sezary cells:" Exploring the Molecular Basis of CTCL to Identify Better Treatments Click here
Madeleine Duvic, M.D., Professor of Internal Medicine and Deputy Chairman of the Department of Dermatology at The University of Texas, MD Anderson Cancer Center in Houston, Texas, explores the molecular underpinnings of CTCL to highlight targets for established and emerging therapies.